The Patent Finder
US

Ophthalmic Compositions of Rifamycins and Uses Thereof

US 11,850,213 In force
OverviewFamilyAssignmentsSources & methods

Also listed on AMD (U.S.) Holdings, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Feb 11, 2036 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Filed Nov 13, 2020 as application 17/098,272 · Granted Dec 26, 2023
Base term plus 206 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2015 2036
Clock starts
Jul 20, 2015
Term ends
Feb 11, 2036
Granted
Dec 26, 2023
base term patent term adjustment Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
206
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 206 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jul 20, 2015, when application PCT/US2015/041196, the earliest non-provisional in its chain, was filed (this one was filed Nov 13, 2020); a parent in its chain could not be resolved (the next row)Jul 20, 2035High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustment+206 days, USPTO patent term adjustment recordFeb 11, 2036High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderFeb 11, 2036Medium confidence

This family

Application PCT/US2015/041196PCT application
no patent term
no patent term
Application 15/327,951Abandoned
not computed
not computed
US 11,850,213this patent
Feb 2036
Feb 2036
Application 18/507,906Pending
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Oct 30, 2023
Reel 65388, frame 535
Serizawa, HiroakiAMD Therapeutics LLCAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited